Overview
GlaxoSmithKline Wind Project is a 7.5 MW onshore wind farm in the United Kingdom, owned by GlaxoSmithKline and operational to support renewable energy goals.
The GlaxoSmithKline Wind Project is an onshore wind farm located in the United Kingdom, with a capacity of 7.5 MW. It is owned by GlaxoSmithKline and is currently operational, contributing to the company's renewable energy portfolio. The facility operates under the UK's renewable energy framework, which includes Contracts for Difference (CfD) and the Renewables Obligation (RO). Onshore wind is a mature technology in the UK, and this project represents a medium-scale installation typical of corporate renewable energy initiatives. As a corporate wind project, it helps GlaxoSmithKline reduce its carbon footprint and energy costs. The UK's strong wind resource and supportive policies make such projects viable, supporting the country's target of net-zero emissions by 2050.
Environmental context
The wind farm is located in a region with favorable wind speeds, typical for onshore wind development in the UK. Environmental considerations include potential impacts on local bird and bat populations, as well as visual landscape effects. The project contributes to reducing greenhouse gas emissions and supports the UK's transition to renewable energy.
Frequently asked questions
The GlaxoSmithKline Wind Project is located in the United Kingdom, at coordinates 55.5979 N, -4.6339 W.
The GlaxoSmithKline Wind Project has a capacity of 7.5 megawatts (MW), making it a medium-scale onshore wind farm.
The project is owned by GlaxoSmithKline, a global pharmaceutical company, as part of its renewable energy and sustainability initiatives.
Onshore wind in the UK is supported by the Contracts for Difference (CfD) scheme and the Renewables Obligation (RO), which provide financial incentives for renewable energy generation.
The project generates clean electricity, reducing reliance on fossil fuels and helping GlaxoSmithKline meet its carbon reduction targets. It also contributes to the UK's goal of achieving net-zero emissions by 2050.